Abstract
Cancer patients need better anticancer drugs, and medicinal chemistry can play a critical role in the discovery of these drugs. For an efficient drug discovery process, chemists working on the synthesis of potential anticancer agents need to use reliable screening methods. These methods should not only detect the compounds with the highest therapeutic potential, but should also predict whether such potential is high enough to deserve additional attention. Unfortunately, the current strategies for assessing anticancer activity in vitro are unable to do this reliably. This review article analyzes these strategies and describes an alternative screening approach. It is based on establishing suitable experimental conditions to detect compounds that improve the selective cytotoxicity of the drugs used in cancer therapy. This patient-oriented approach is easy to implement and may help medicinal chemists, and other researchers involved in cancer drug discovery, assess in vitro anticancer activity more reliably.
Keywords: Antitumor activity, cancer, cytotoxic activity, drug discovery, screening, selectivity.
Current Medicinal Chemistry
Title:A Simple and Reliable Approach for Assessing Anticancer Activity In Vitro
Volume: 22 Issue: 11
Author(s): Miguel Lopez-Lazaro
Affiliation:
Keywords: Antitumor activity, cancer, cytotoxic activity, drug discovery, screening, selectivity.
Abstract: Cancer patients need better anticancer drugs, and medicinal chemistry can play a critical role in the discovery of these drugs. For an efficient drug discovery process, chemists working on the synthesis of potential anticancer agents need to use reliable screening methods. These methods should not only detect the compounds with the highest therapeutic potential, but should also predict whether such potential is high enough to deserve additional attention. Unfortunately, the current strategies for assessing anticancer activity in vitro are unable to do this reliably. This review article analyzes these strategies and describes an alternative screening approach. It is based on establishing suitable experimental conditions to detect compounds that improve the selective cytotoxicity of the drugs used in cancer therapy. This patient-oriented approach is easy to implement and may help medicinal chemists, and other researchers involved in cancer drug discovery, assess in vitro anticancer activity more reliably.
Export Options
About this article
Cite this article as:
Lopez-Lazaro Miguel, A Simple and Reliable Approach for Assessing Anticancer Activity In Vitro, Current Medicinal Chemistry 2015; 22 (11) . https://dx.doi.org/10.2174/0929867322666150209150639
DOI https://dx.doi.org/10.2174/0929867322666150209150639 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Optimal Diagnosis of Urothelial Carcinoma of the Bladder
Current Cancer Therapy Reviews Progress in the Development of Aminopeptidase N (APN/CD13) Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Nano-Enabled Drug Delivery in Cancer Therapy: Literature Analysis Using the MeSH System
Pharmaceutical Nanotechnology Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer
Current Cancer Drug Targets Role of Unani Medicines in Cancer Control and Management
Current Drug Therapy Carcinogenicity and Chronic Rodent Toxicity of the Selective Progesterone Receptor Modulator Ulipristal Acetate
Current Drug Safety In Vitro Regulatory Effect of Epididymal Serpin CRES on Protease Activity of Proprotein Convertase PC4/PCSK4
Current Molecular Medicine Oleamide Derivatives are Prototypical Anti-Metastasis Drugs that Act by Inhibiting Connexin 26
Current Drug Safety The Rational Design of Anticancer Platinum Complexes: The Importance of the Structure-Activity Relationship
Current Medicinal Chemistry Attacking c-Myc: Targeted and Combined Therapies for Cancer
Current Pharmaceutical Design Genetic Engineering - A New Era for Cancer Immunotherapy?
Current Cancer Therapy Reviews Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine
Anti-Cancer Agents in Medicinal Chemistry Lymphoblastoid Cell Lines Models of Drug Response: Successes and Lessons from this Pharmacogenomic Model
Current Molecular Medicine Promotion of Cortico-Cerebral Precursors Expansion by Artificial pri-miRNAs Targeted Against the Emx2 Locus
Current Gene Therapy Bioactive Compounds Containing Benzoxadiazole, Benzothiadiazole, Benzotriazole
Current Bioactive Compounds Potential Anti-cancer Drugs Commonly Used for Other Indications
Current Cancer Drug Targets Promising Protective Effects of Chrysin in Cardiometabolic Diseases
Current Drug Targets Target-oriented Mechanisms of Novel Herbal Therapeutics in the Chemotherapy of Gastrointestinal Cancer and Inflammation
Current Pharmaceutical Design <i>Uncaria tomentosa</i> (Willd. ex Schult.): Focus on Nutraceutical Aspects
Current Bioactive Compounds It is All About Proteases: From Drug Delivery to In Vivo Imaging and Photomedicine
Current Medicinal Chemistry